{ "@context": "https://schema.org", "@type": "Organization", "name": "Earli Inc.", "alternateName": "Earli", "url": "https://www.earli.com/", "logo": "https://www.earli.com/images/logo.png", "description": "Earli is a biotechnology company focused on the early detection and treatment of cancer using synthetic biopsy technology to identify and destroy cancer cells at their earliest stages.", "foundingDate": "2018", "founders": [ { "@type": "Person", "name": "Cyriac Roeding" }, { "@type": "Person", "name": "Dr. David Suhy" } ], "address": { "@type": "PostalAddress", "streetAddress": "161 Oyster Point Boulevard, Suite 201", "addressLocality": "South San Francisco", "addressRegion": "CA", "postalCode": "94080", "addressCountry": "US" }, "sameAs": [ "https://www.linkedin.com/company/earli/", "https://twitter.com/earli_inc" ], "contactPoint": { "@type": "ContactPoint", "contactType": "general inquiries", "email": "info@earli.com" } }

"Malignant growth and normal growth are so genetically intertwined that unbraiding the two might be one of the most significant scientific challenges faced by our species ."
Prologue in The Emperor Of All Maladies
Pulitzer Prize 2011, Siddhartha Mukherjee
Earli designs programmable genetic constructs that turn on only in cancer cells and force them to make their own therapies to kill themselves.
See Earli's science →